Cargando…

Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience

BACKGROUND/AIM: The HIV-infected population is aging, and the concomitant comorbidities increase the likelihood of polypharmacy. There is a scarcity of data for determining drug-related problems in people living with HIV/AIDS (PLWHA). MATERIALS AND METHODS: This cross-sectional study was carried out...

Descripción completa

Detalles Bibliográficos
Autores principales:	KARA, Emre, İNKAYA, Ahmet Çağkan, AYDIN HAKLI, Duygu, DEMİRKAN, Kutay, ÜNAL, Serhat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350848/ https://www.ncbi.nlm.nih.gov/pubmed/30761883 http://dx.doi.org/10.3906/sag-1807-295

Ejemplares similares

May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
por: Kara, Emre, et al.
Publicado: (2020)

Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital
por: CEYLAN, Erdal, et al.
Publicado: (2019)

Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19
por: Kara, Emre, et al.
Publicado: (2020)

Functional responsiveness of memory T cells from COVID-19 patients
por: Tavukcuoglu, Ece, et al.
Publicado: (2021)

Does information by pharmacists convince the public to get vaccinated for pneumococcal disease and herpes zoster?
por: Bayraktar-Ekincioglu, Aygin, et al.
Publicado: (2021)

What is polypharmacy in people living with HIV/AIDS? A systematic review
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2022)

Perinatal outcomes of twenty-five human immunodeficiency virus-infected pregnant women: Hacettepe University experience
por: İnkaya, Ahmet Çağkan, et al.
Publicado: (2020)

Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV Infected Patients
por: Korten, Volkan, et al.
Publicado: (2017)

Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
por: Tavukcuoglu, Ece, et al.
Publicado: (2023)

The Reliability and Validity of The Turkish Form of Berger HIV Stigma Scale
por: YILDIZ, Mevhibe İrem, et al.
Publicado: (2021)

COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey
por: Hagens, Arnold, et al.
Publicado: (2021)

Actinomyces-associated Lesions Located in the Gingiva: Case Report of Rare Gingival Lesions
por: Acar, Buket, et al.
Publicado: (2017)

The evaluation of relationship between polypharmacy and anticholinergic burden scales
por: Okudur, Saadet Koc, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey
por: Sonmezer, Meliha Cagla, et al.
Publicado: (2022)

1494. Impact of Polypharmacy on Gait Speed and Falls in Older People Living with HIV.
por: Kosana, Priya, et al.
Publicado: (2023)

Knowledge, attitudes, and practices regarding vaccination among community pharmacists
por: Ozdemir, Nesligul, et al.
Publicado: (2022)

Factors associated with intention of clinical pharmacists and candidates to provide pharmaceutical care: application of theory planned behaviour
por: Tecen-Yucel, Kamer, et al.
Publicado: (2023)

POLYPHARMACY IN ASSISTED LIVING
por: Galik, Elizabeth
Publicado: (2022)

Relationship Between Polypharmacy and Quality of Life Among People in 24 Countries Living With HIV
por: Okoli, Chinyere, et al.
Publicado: (2020)

Conjunctival Flora in Diabetic and Nondiabetic Individuals
por: Adam, Mehmet, et al.
Publicado: (2015)

A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
por: Sarohan, Aziz Rodan, et al.
Publicado: (2021)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome
por: GÖKER, Hakan, et al.
Publicado: (2020)

Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening
por: Hilmi Çekin, Ayhan, et al.
Publicado: (2023)

Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil
por: da Silva, Robson Pierre Nascimento, et al.
Publicado: (2023)

Psychological, Social, and Familial Problems of People Living with HIV/AIDS in Iran: A Qualitative Study
por: Dejman, Masoumeh, et al.
Publicado: (2015)

Behçet’s Disease-related Budd–Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature
por: Erul, Enes, et al.
Publicado: (2022)

Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis
por: Danjuma, Mohammed I., et al.
Publicado: (2022)

Tuberculosis control in people living with HIV/AIDS
por: Magnabosco, Gabriela Tavares, et al.
Publicado: (2016)

Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study
por: Ozdemir, Nesligul, et al.
Publicado: (2023)

Problem-Based Learning Could Tackle the Issue of Insufficient Education and Adherence in People Living With HIV/AIDS
por: Zhang, Yang, et al.
Publicado: (2019)

Health Needs of People Living with HIV/AIDS: From the Perspective of Policy Makers, Physicians and Consultants, and People Living with HIV/AIDS
por: MORADI, Ghobad, et al.
Publicado: (2014)

The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis
por: Sumer, Sua, et al.
Publicado: (2013)

The investigation of Strongyloides stercoralis seroprevalence in immunosupressed patients in Turkey
por: KAYA, Filiz, et al.
Publicado: (2019)

Polypharmacy - is there a cure for drug therapy problems?
por: Orehovački, Helena, et al.
Publicado: (2023)

Polypharmacy among people living with type 2 diabetes mellitus in rural communes in Vietnam
por: Thi Bui, Dieu Huyen, et al.
Publicado: (2021)

Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016
por: Ware, Deanna, et al.
Publicado: (2018)

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review
por: He, Jiamin, et al.
Publicado: (2023)

936. Evaluating the Impact of Polypharmacy on Virologic Success in People with HIV
por: Jimenez, Humberto R, et al.
Publicado: (2020)

Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe
por: Gökengin, Deniz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tb1nbavjg6rq9ie1pr8du4fp5g